Elinor J. Sawyer
Advanced in Ring Chromosome 12

Elinor J. Sawyer

London, ENG, GB 
Advanced in Ring Chromosome 12
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Elinor Sawyer practices in London, United Kingdom. Ms. Sawyer is rated as an Advanced expert by MediFind in the treatment of Ring Chromosome 12. Her top areas of expertise are Breast Cancer, Ring Chromosome 12, Ectopic Pregnancy, Familial Prostate Cancer, and Mastectomy.

Her clinical research consists of co-authoring 205 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Ring Chromosome 12.

Gender
Female

Locations

London, ENG SE19RT, United Kingdom
Other Locations
St. Mary's Hospital, Oxford, ENG, United Kingdom
Cambridge, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase II Study of ROS1 Targeting With Crizotinib in Advanced E-cadherin Negative, ER Positive Lobular Breast Cancer, Diffuse Gastric Cancer, Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours
Phase II Study of ROS1 Targeting With Crizotinib in Advanced E-cadherin Negative, ER Positive Lobular Breast Cancer, Diffuse Gastric Cancer, Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours
Enrollment Status: Active_not_recruiting
Publish Date: December 22, 2023
Intervention Type: Drug
Study Drugs: Crizotinib, Fulvestrant
Study Phase: Phase 2

205 Total Publications

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Journal: Nature communications
Published: September 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sawyer's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile